Literature DB >> 3881957

Clinical and immunological follow-up of patients with severe renal disease in Wegener's granulomatosis.

I J ten Berge, J M Wilmink, C J Meyer, J Surachno, K H ten Veen, T G Balk, P T Schellekens.   

Abstract

Clinical and immunological data are reported of 12 patients suffering from Wegener's granulomatosis and severe renal involvement. Although 9 patients recovered from their acute illness, a long-term follow-up a relapse occurred in 4 of these 9 patients. Therefore, lifelong follow-up in this group patients seems to be mandatory. Extensive immunological investigations did not provide evidence for humoral mechanisms underlying the pathogenesis of this disease; T lymphocyte subsets in peripheral blood as well as functional reactivity of lymphocytes in vitro were also normal. However, none of the patients was able to mount a primary cellular immune response in vivo. On the other hand, kidney biopsy specimens obtained before the initiation of drug therapy revealed periglomerular and interstitial cellular infiltrations consisting predominantly of T lymphocytes with a ratio Leu 3a (OKT4)/Leu 2a (OKT8) of 5:1. This may indicate that a type IV (delayed-type) hypersensitivity reaction takes place in the kidney. These findings suggest that an abnormal cellular immunoreactivity plays a major role in the pathogenesis of Wegener's granulomatosis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3881957     DOI: 10.1159/000166898

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  8 in total

1.  Amphipathic variable region heavy chain peptides derived from monoclonal human Wegener's anti-PR3 antibodies stimulate lymphocytes from patients with Wegener's granulomatosis and microscopic polyangiitis.

Authors:  E Peen; C Malone; C Myers; R C Williams; A B Peck; E Csernok; W L Gross; R Staud
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

Review 2.  Immunopathological aspects of systemic vasculitis.

Authors:  I M Bajema; E C Hagen; F Ferrario; E de Heer; J A Bruijn
Journal:  Springer Semin Immunopathol       Date:  2001

Review 3.  New horizons in renal vasculitis.

Authors:  J S Cameron
Journal:  Klin Wochenschr       Date:  1991-09-03

4.  Spontaneous and induced immunoglobulin synthesis and anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis: relation to leukocyte subpopulations in blood and active lesions.

Authors:  N Rasmussen; J Petersen; E Ralfkiaer; S Avnstøm; A Wiik
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

5.  T cell receptor (TCR) V gene usage in patients with systemic necrotizing vasculitis.

Authors:  R Giscombe; J Grunewald; S Nityanand; A K Lefvert
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

6.  T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG).

Authors:  E Brouwer; C A Stegeman; M G Huitema; P C Limburg; C G Kallenberg
Journal:  Clin Exp Immunol       Date:  1994-12       Impact factor: 4.330

7.  Activated CD4+ and CD8+ T-cell subsets in Wegener's granulomatosis.

Authors:  M Schlesier; T Kaspar; J Gutfleisch; G Wolff-Vorbeck; H H Peter
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

Review 8.  Renal disease and vasculitis.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1988-10       Impact factor: 3.714

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.